5:33 PM
Jun 12, 2012
 |  BC Extra  |  Company News

GE, BGI in sequencing deal

GE Healthcare partnered with BGI (Shenzen, China) to develop stem cell-derived assays for use in drug development and toxicity testing. Under...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >